T 0519/24 of 05.02.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T051924.20260205
- Date of decision
- 5 February 2026
- Case number
- T 0519/24
- Online on
- 30 October 2026
- Petition for review of
- -
- Application number
- 14718957.5
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pharmaceutical composition, methods for treating and uses thereof
- Applicant name
- Boehringer Ingelheim International GmbH
- Opponent name
- ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
SANDOZ AG
Kraus & Lederer PartGmbB
STADA Arzneimittel AG - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83European Patent Convention Art 56
- Keywords
- Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of claims 1 to 8 of auxiliary request 4 filed on 22 December 2023 and a description to be possibly adapted thereto.